|
|
|
|
| LEADER |
01905nmm a2200301 u 4500 |
| 001 |
EB000637120 |
| 003 |
EBX01000000000000000490202 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783034888318
|
| 100 |
1 |
|
|a Stockley, Robert
|e [editor]
|
| 245 |
0 |
0 |
|a Molecular Biology of the Lung
|h Elektronische Ressource
|b Volume I: Emphysema and Infection
|c edited by Robert Stockley
|
| 250 |
|
|
|a 1st ed. 1999
|
| 260 |
|
|
|a Basel
|b Birkhäuser
|c 1999, 1999
|
| 300 |
|
|
|a VIII, 216 p
|b online resource
|
| 505 |
0 |
|
|a 1. Application of Transgenic and Gene-Targeted Mice to Dissect Mechanisms of Lung Disease -- Emphysema -- 2. Models of Genetic Emphysema: The C57B1/6J Mice and their Mutants: Tight-Skin, Pallid and Beige Giuseppe Lungarella, Eleonora Cavarra and -- 3. ?1-Antitrypsin Deficiency -- 4. Recombinant SLPI: Emphysema and Asthma -- 5. Elastase Inhibitors in the Lung: Expression and Functional Relationships -- 6. Regulation of Neutrophil Proteinases -- 7. Control of Connective Tissue Genes -- Infection -- 8. Genetic Models of Bacterial Lung Infection -- 9. Genetics of Bacteria: Role in Pathogenesis of Infection of the Respiratory Tract -- 10. Polymerase Chain Reaction in the Diagnosis of Respiratory Tract Infections -- 11. Cystic Fibrosis -- 12. Respiratory Bacterial Infections in Patients with Cystic Fibrosis: Pathogenicity and Implications for Serine Proteinase Inhibitor Therapy
|
| 653 |
|
|
|a Pneumology
|
| 653 |
|
|
|a Medicine / Research
|
| 653 |
|
|
|a Biology / Research
|
| 653 |
|
|
|a Respiratory organs / Diseases
|
| 653 |
|
|
|a Biomedical Research
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Respiratory Pharmacology and Pharmacotherapy
|
| 028 |
5 |
0 |
|a 10.1007/978-3-0348-8831-8
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-0348-8831-8?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.2
|